Prudential Financial
PVLA

Prudential Financial’s Palvella Therapeutics PVLA Stock Holding History

Prudential Financial’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
+1,755
New +$213K ﹤0.01% 2136
2024
Q2 		– Sell
-2,760
Closed -$40.5K – 2809
2024
Q1 		$40.5K Buy
2,760
+1,382
+100% +$19.2K ﹤0.01% 2610
2023
Q4 		$20.1K Hold
1,378
– – ﹤0.01% 2617
2023
Q3 		$32.8K Buy
1,378
+1,230
+831% +$26.4K ﹤0.01% 2541
2023
Q2 		$1.95K Buy
148
+3
+2% +$182 ﹤0.01% 2611
2023
Q1 		$11.3K Hold
145
– – ﹤0.01% 2584
2022
Q4 		$12.1K Hold
145
– – ﹤0.01% 2575
2022
Q3 		$13K Hold
145
– – ﹤0.01% 2638
2022
Q2 		$22K Buy
+145
New +$26.5K ﹤0.01% 2643
2021
Q1 		– Sell
-134
Closed -$26K – 2541
2020
Q4 		$26K Hold
134
– – ﹤0.01% 2430
2020
Q3 		$22K Sell
134
-352
-72% -$80.1K ﹤0.01% 2418
2020
Q2 		$121K Buy
+486
New +$114K ﹤0.01% 2320
2019
Q3 		– Sell
-134
Closed -$50K – 2482
2019
Q2 		$50K Buy
134
+1
+0.8% +$298 ﹤0.01% 2421
2019
Q1 		$36K Sell
133
-70
-34% -$16.6K ﹤0.01% 2409
2018
Q4 		$43K Buy
+203
New +$63K ﹤0.01% 2339

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Prudential Financial's PVLA Position: Q2 2026 in Review

Prudential Financial opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 1,755 shares worth $268K. The stake represents ﹤0.01% of the portfolio and ranks #2136 among its holdings. This is a return to the name: Prudential Financial previously reported a position in PVLA as recently as Q1 2024.

Prudential Financial first reported a position in PVLA in Q4 2018 and has held it in 15 quarters since. 197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Prudential Financial held 1,755 shares of Palvella Therapeutics worth $268K as of Q2 2026.
  • Palvella Therapeutics was a new Prudential Financial position in Q2 2026.
  • Palvella Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2136 holding.
  • Prudential Financial first reported a position in Palvella Therapeutics in Q4 2018 and has held it in 15 quarters since.
  • 197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.